Oxybutynin Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Oxybutynin Hydrochloride
Health Canada Patents

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Oxybutynin Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 13 USDMF, 11 CEP/COS, 3 JDMF, 4 EU WC, 1 KDMF, 12 NDC API, 9 Listed Suppliers, $ API Reference Price

27 API Suppliers
13 USDMF
11 CEP/COS
3 JDMF
4 EU WC
1 KDMF
12 NDC API
9 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

94 FDF Dossiers, 61 FDA Orange Book, 12 Europe, 10 Canada, 5 South Africa, 6 Listed Dossiers

94 FDF Dossiers
61 FDA Orange Book
12 Europe
10 Canada
5 South Africa
6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TRANSDERMAL - 10% (100MG/PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;TRANSDERMAL - 10% (100MG/PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Evonik, 2 Rochem International Inc, 20 SPI Pharma, 7 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 7 Kirsch Pharma, 1 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 30 BASF, 2 CD Formulation, 1 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 8 Ideal Cures, 5 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 2 The Dow Chemical Company, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 40 Direct Compression, 36 Controlled & Modified Release, 33 Granulation, 31 Disintegrants & Superdisintegrants, 30 Parenteral, 30 Solubilizers, 29 Taste Masking, 29 Thickeners and Stabilizers, 26 Film Formers & Plasticizers, 23 Lubricants & Glidants, 19 Topical, 19 Chewable & Orodispersible Aids, 13 Co-Processed Excipients, 9 Emulsifying Agents, 7 Rheology Modifiers, 6 Surfactant & Foaming Agents, 6 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

71 Fillers, Diluents & Binders
63 Coating Systems & Additives
40 Direct Compression
36 Controlled & Modified Release
33 Granulation
31 Disintegrants & Superdisintegrants
30 Parenteral
30 Solubilizers
29 Taste Masking
29 Thickeners and Stabilizers
26 Film Formers & Plasticizers
23 Lubricants & Glidants
19 Topical
19 Chewable & Orodispersible Aids
13 Co-Processed Excipients
9 Emulsifying Agents
7 Rheology Modifiers
6 Surfactant & Foaming Agents
6 API Stability Enhancers
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

17 News #PharmaBuzz

17 News #PharmaBuzz

GLOBAL SALES INFORMATION

34 US Medicaid Prescriptions, 13 Regulatory FDF Prices

34 US Medicaid Prescriptions
13 Regulatory FDF Prices

MARKET PLACE

10 APIs

10 APIs

PATENTS & EXCLUSIVITIES

3 US Patents, 6 Health Canada Patents

3 US Patents
6 Health Canada Patents

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 642 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 3Gowling WLG (Canada) LLP

02 3Janssen Inc.

filter Patent Reset all filters

6 All

01 32218714

02 22504021

03 12718277

filter Product Reset all filters

6 All

01 6Oxybutynin Chloride

filter Dosage Reset all filters

6 All

01 3Extended Release Tablet

02 2Gel

03 1Metered Dose Pump

filter Exp Date Reset all filters

6 All

01 32016-05-08

02 32023-10-31

Product Main Page

01

Gowling WLG (Canada) LLP

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-10-31

Date Granted : 2013-08-13

Oxybutynin Chloride

Brand Name : GELNIQUE

Patent Number : 2504021

Filing Date : 2003-10-31

Strength per Unit : 100 mg / g

Dosage Form : Metered Dose Pump

Human Or VET : Human

Route of Administration : Topical

Patent Expiration Date : 2023-10-31

Date Granted : 2013-08-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling WLG (Canada) LLP

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-10-31

Date Granted : 2013-08-13

Oxybutynin Chloride

Brand Name : GELNIQUE

Patent Number : 2504021

Filing Date : 2003-10-31

Strength per Unit : 100 mg / g

Dosage Form : Gel

Human Or VET : Human

Route of Administration : Topical

Patent Expiration Date : 2023-10-31

Date Granted : 2013-08-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling WLG (Canada) LLP

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-10-31

Date Granted : 2015-02-03

Oxybutynin Chloride

Brand Name : GELNIQUE

Patent Number : 2718277

Filing Date : 2003-10-31

Strength per Unit : 100 mg / g

Dosage Form : Gel

Human Or VET : Human

Route of Administration : Topical

Patent Expiration Date : 2023-10-31

Date Granted : 2015-02-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Janssen Inc.

Oxybutynin Chloride

iPHEX India

Not Confirmed

Janssen Inc.

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-05-08

Date Granted : 2005-08-23

Oxybutynin Chloride

Brand Name : DITROPAN XL

Patent Number : 2218714

Filing Date : 1996-05-08

Strength per Unit : 5mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-05-08

Date Granted : 2005-08-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Janssen Inc.

Oxybutynin Chloride

iPHEX India

Not Confirmed

Janssen Inc.

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-05-08

Date Granted : 2005-08-23

Oxybutynin Chloride

Brand Name : DITROPAN XL

Patent Number : 2218714

Filing Date : 1996-05-08

Strength per Unit : 10mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-05-08

Date Granted : 2005-08-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Janssen Inc.

Oxybutynin Chloride

iPHEX India

Not Confirmed

Janssen Inc.

iPHEX India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-05-08

Date Granted : 2005-08-23

Oxybutynin Chloride

Brand Name : DITROPAN XL

Patent Number : 2218714

Filing Date : 1996-05-08

Strength per Unit : 15mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-05-08

Date Granted : 2005-08-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!